Neudecker et al. indicated that the expression of miR-223-3p was increased in subjects with inflammatory bowel disease (IBD) and that it limited the inflammatory response by inhibiting the NLRP3 inflammasome in the intestinal nonspecific immune responses [44]. The gene discussed is NLRP3; the disease is inflammatory bowel disease.